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For a long time corynebacteria have not been accepted as
true pathogens, but as contaminants, due to insufficient data
on their role in human infections.1 The aim of our study was
to investigate the characteristics of patients experiencing
urinary infections due to corynebacteria. Between 2000 and
2001, 9410 urinary specimens were cultured in sheep blood
agar and eosin methylene blue agar. All cultures included
were obtained from single patients. The agar plates were
incubated for 7 days. The corynebacterial samples exceeding
100 000 cfu/ml were evaluated. Catalase positive, grey—
white and opaque colonies with Gram-positive bacilli resem-
bling Chinese letters were processed. For the identification
of the bacteria an automatic API system involving 20 enzy-
matic reactions (BioMerieux, France) was used,2 after which
both the patients and their clinicians were contacted in order
to evaluate each case. When the patient was diagnosed with
symptomatic urinary tract infection,3 they were evaluated
for any underlying pathology.
In our study, 12 corynebacterial species were isolated from
54 patients as the causative agents of urinary infections.When
the patients were assessed 46 (85%) underlying pathologies
were observed. The following caseswere recorded: 11 cases of
chronic renal insufficiency (five C. jeikeium, four C. urealyti-
cum, two C. striatum), one chronic renal failure plus diabetes
mellitus (C. jeikeium), seven chronic urinary infection (two C.
amycolatum, two CDC-G (Centers for Disease Control Group
G), one C. aquaticum, one C. jeikeium, one C. urealyticum),
six chronic pyelonephritis (two C. jeikeium, one C. amycola-
tum, one C. striatum, one C. urealyticum, one C. renale),
three chronic prostatitis (two C. seminale, oneC. aquaticum),
two urinary bladder carcinoma (one C. jeikeium, one C.
afermentans), two urinary stricture (one C. striatum, one
CDC-G), two burn injuries (one C. macginleyi, one C. coyleae)
and two urolithiasis (one C. amycolatum, one C. aquaticum),
one acute renal failure (C. striatum), oneadrenal insufficiency
(C. amycolatum), one osteoporosis (C. urealyticum), one
ovarian adenocarcinoma (C. urealyticum), one pancreas car-
cinoma (C. striatum), one prostate carcinoma (C. amycola-
tum), one gunshot wound (C. pseudodiphtheriticum), one
diabetic nephropathy (C. striatum), one hand reconstruction
(C. jeikeium), and one cranial trauma (C. amycolatum).
When the underlying pathologies were assessed, it was
seen that 37 of 46 (80.4%) concomitant diseases were
associated with the urinary system. Moreover, 68.5% of
all urinary infections due to corynebacteria were relatedto the same system (CDC-G). Underlying pathologies were
not observed for eight urinary infections (three C. urealy-
ticum, two C. pseudodiphtheriticum, two C. striatum, one
CDC-G).
In conclusion, if corynebacterial pathogens are the cau-
sative agents of urinary infections, premorbid conditions
which are primarily related to chronic disorders of the urinary
system are quite common. Furthermore, when corynebac-
teria are recovered as the causative agents of urinary infec-
tions, clinicians should take serious underlying urinary
diseases into consideration.
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nosocomial bloodstream infection in a tertiary
referral hospital in the United Arab Emirates
Data on antimicrobial resistance and patterns of nosocomial
infection are lacking for the United Arab Emirates (UAE).1
From February 2001 to May 2002, we performed a surveil-
lance study on nosocomial bloodstream infection in a ter-
tiary referral hospital in the UAE. The laboratory and clinical
data on all positive blood cultures were reviewed pros-pectively. Parameters used to define strains as clinically
significant and representing true infection rather than con-
tamination, included the identity of the microorganism, the
presence of more than one blood culture with the same
microorganism and the presence of the same microorganism
as that found in the blood in another site. Nosocomial
bloodstream infection was defined as bacteremia occurring
>48 hours or longer after admission.2 Blood cultures
were analyzed using theVital analyzer (BioMerieux, France).
All antimicrobial tests were performed by disc diffusion in
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Table 1 Ranked order of the commonest causes of nosoco-
mial bloodstream infection, Tawam Hospital, February 2001
to May 2002
Rank Organism n = 281 (%)
1 Coagulase-negative staphylococci 84 (29.9)
2 Klebsiella spp 29 (10.3)
3 Enterobacter spp 24 (8.5)
4 Acinetobacter spp 22 (7.8)
5 Escherichia coli 20 (7.1)
6 Staphylococcus aureus 17 (6.0) a
7 Pseudomonas aeruginosa 15 (5.3)
8 Candida spp 15 (5.3)
9 Enterococcus spp 9 (3.2) b
10 Viridans streptococci 7 (2.5)
a 1/17 (5.9%) S. aureus strains were methicillin-resistant
(MRSA).
b Glycopeptide-resistant enterococci (GRE) were not detected.accordance with criteria from the National Committee for
Clinical Laboratory Standards (NCCLS), wherever possible.3
Consecutive isolates and their susceptibility patterns
were entered manually into a database. During the period
2000—2001, Epi Info version 6.02 was used and in 2002,
WHONET.4,5
There were 281 clinically significant isolates. Gram-posi-
tive organisms accounted for 47% of isolates, Gram-negative
48% and fungi 5%. Anaerobes were isolated from one episode.
Eighteen percent of episodes were polymicrobial. Table 1
shows the ranked order of isolates.
The pattern of organisms was different from those
reported elsewhere in the world.6—9 The most notable
difference was the predominance of Gram-negative organ-
isms compared with Gram-positive. Although coagulase-
negative staphylococci (CoNS) made up a similar proportion
to that found in other reports (29.9%), Enterococcus spp
were infrequent isolates (3.2%). Of the 6% proportion of
Staphylococcus aureus strains, 5.9% were methicillin-resis-
tant (MRSA) and glycopeptide-resistant enterococci (GRE)
were not detected during the study period. Acinetobacter
spp (7.8%) were common pathogens compared with other
Gram-negative organisms. The pattern of organisms is very
different from that found in North America and most of
Europe, but shares some similarities, such as the predomi-
nance of Gram-negative organisms, the low frequency of
Enterococcus spp and the relatively higher frequency of
Acinetobacter spp, with data reported from Latin America.9
The incidence of Candida spp is higher than reports from
Europe, but lower than from the USA.6,8 Overall, while
there are similarities with worldwide data, the pattern is
apparently unique. These data emphasize the fact that
patterns of infection vary geographically and hence there
is a need for local data. Comparable data from the UAE are
not available in the literature and further work is needed to
establish whether the patterns of organisms reported here
are typical for the UAE.
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